Authors
Jiling Liu, Lei Wang, Aiwen Wang, Jiashuo Wang, Mengyi Wei, Xueqian Jing, Huiling Yao, Nana Ma, Lining Zhao, Riheng Li, Sijun Dong
Published in
Environmental pollution (Barking, Essex : 1987). Pages 129463. Nov 10, 2026. Epub Nov 10, 2026.
Abstract
Polycyclic aromatic hydrocarbons (PAHs), especially the PAH4 mixture, are common environmental pollutants. However, the effects of dietary PAH4 exposure on the gut microbiota and intestinal barrier integrity are not fully understood. We conducted four experiments in BALB/c mice to address this knowledge gap. First, the mice received three graded doses of PAH4 by daily gavage for 28 days. PAH4 caused dose-dependent gut dysbiosis and reduced short-chain fatty acid (SCFA) production, which in turn inhibited the activity of the GPR43 pathway. Consequently, colonic inflammation was triggered, intestinal barrier integrity was impaired, and the LPS/TLR4/NF-κB cascade was activated. Second, we compared exposure to the PAH4 mixture with exposure to each individual congener (benzo[a]pyrene [BaP], chrysene [CHR], benz[a]anthracene [BaA], and benzo[b]fluoranthene [BbF]). The mixture induced more severe microbial dysbiosis and caused stronger colonic inflammation and greater barrier damage. Thus, PAH4 exhibited combined toxic effects. Third, we used an antibiotic cocktail to deplete commensal bacteria. Microbiota depletion largely abolished PAH4-induced inflammation and barrier injury. These findings clearly show that the gut microbiota is an essential mediator of PAH4 intestinal toxicity. Fourth, we treated mice with 4-CMTB, a selective GPR43 agonist. This agonist activated GPR43 and effectively reversed the PAH4-induced colonic inflammation that restored barrier function. Therefore, we confirmed the causal role of the SCFA-GPR43 axis, and our study clarified the dose-response relationship of PAH4. It also reveals the combined toxicity of the mixture and reveals a microbiota-dependent mechanism. These findings provide reference data for environmental risk assessment, which offer new insights for preventing and treating PAH-related intestinal disorders.
PMID:
43009120
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 14
- Comments 0